Literature DB >> 22665528

Positron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?

Andrea Gallamini, Lale Kostakoglu.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22665528      PMCID： PMC3366642          DOI： 10.3324/haematol.2012.063909

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Authors:  Martin Hutchings; Annika Loft; Mads Hansen; Lars Møller Pedersen; Thora Buhl; Jesper Jurlander; Simon Buus; Susanne Keiding; Francesco D'Amore; Anne-Marie Boesen; Anne Kiil Berthelsen; Lena Specht
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?

Authors:  J O Armitage; F R Loberiza
Journal:  Ann Oncol       Date:  2006-06       Impact factor: 32.976

4.  Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records.

Authors:  J A Radford; A Eardley; C Woodman; D Crowther
Journal:  BMJ       Date:  1997-02-01

5.  Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.

Authors:  Tarec Christoffer El-Galaly; Karen Juul Mylam; Peter Brown; Lena Specht; Ilse Christiansen; Lars Munksgaard; Hans Erik Johnsen; Annika Loft; Anne Bukh; Victor Iyer; Anne Lerberg Nielsen; Martin Hutchings
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

6.  Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.

Authors:  J C Weeks; B Y Yeap; G P Canellos; M A Shipp
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

7.  Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population.

Authors:  M Liedtke; P A Hamlin; C H Moskowitz; A D Zelenetz
Journal:  Ann Oncol       Date:  2006-05-03       Impact factor: 32.976

8.  New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.

Authors:  Andreas Josting; Jeremy Franklin; Michael May; Peter Koch; Maria K Beykirch; Juergen Heinz; Christian Rudolph; Volker Diehl; Andreas Engert
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

9.  High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.

Authors:  Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di Nicola; Sergio Cortelazzo; Rosalba Rosato; Carlo Rosanelli; Nicola Di Renzo; Maurizio Musso; Enzo Pavone; Gino Santini; Alessandra Pescarollo; Alberto De Crescenzo; Massimo Federico; Andrea Gallamini; Patrizia Pregno; Roberta Romano; Paolo Coser; Eugenio Gallo; Mario Boccadoro; Tiziano Barbui; Alessandro Pileri; Alessandro M Gianni; Alessandro Levis
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

10.  Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.

Authors:  Andrea Gallamini; Martin Hutchings; Luigi Rigacci; Lena Specht; Francesco Merli; Mads Hansen; Caterina Patti; Annika Loft; Francesco Di Raimondo; Francesco D'Amore; Alberto Biggi; Umberto Vitolo; Caterina Stelitano; Rosario Sancetta; Livio Trentin; Stefano Luminari; Emilio Iannitto; Simonetta Viviani; Ivana Pierri; Alessandro Levis
Journal:  J Clin Oncol       Date:  2007-07-23       Impact factor: 44.544
View more
  2 in total

1.  Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.

Authors:  Silvia Morbelli; Selene Capitanio; Fabrizio De Carli; Francesca Bongioanni; Enrico De Astis; Maurizio Miglino; Maria Teresa Verardi; Ambra Buschiazzo; Francesco Fiz; Cecilia Marini; Elena Pomposelli; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-19       Impact factor: 9.236

Review 2.  Role of PET in lymphoma.

Authors:  Andrea Gallamini; Anna Borra
Journal:  Curr Treat Options Oncol       Date:  2014-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.